BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:As of 2023\, more than 10 bispecific antibodies have been succ
 essfully approved by the FDA\, and more than 100 are currently in clinica
 l trials\, highlighting biopharma’s continued investment within bispecifi
 c therapeutics.\n\nAs we look to the future of bispecific drugs and focus
  on novel formats and exploring new mechanisms to differentiate from the 
 crowd\, the 15th World Bispecific Summit continues to be the industry’s o
 ne-stop-shop for all your strategic needs within bi\, tri or multi-specif
 ics or even bispecific ADCs or BiTEs.\n\nDrug developers across discovery
 \, preclinical and clinical development are joining forces once more to c
 reate an improved foothold in this exciting area of drug discovery and br
 ing better and more efficacious bispecific drugs to patients across diffe
 rent disease indications.\n\nGiven the reach bispecific drugs can have\, 
 the hunt is on for novel targets that can transform the lives of patients
 \, whether it’s new targets and combinations to improve the safety profil
 e for haematological malignancies\, overcoming the immunosuppressive micr
 oenvironment within solid tumors\, or switching the immune system off in 
 autoimmune disease.\n\nMoving towards more personalized medicine\, profil
 ing bispecific candidates preclinically to ensure the developability has 
 never been more important. Although time consuming\, the benefits in the 
 reduction of the risk and spend is huge in getting candidates into the cl
 inic. Join this meeting to hear novel ideas and concepts\, preclinical da
 ta\, and clinical lessons to enhance the developability of your bispecifi
 c drug.\n\n&nbsp\;\n\nTime: 9:00 AM - 5:00 PM\n
DTEND:20240905T170000
DTSTAMP:20260512T232940Z
DTSTART:20240903T090000
LOCATION:The Royal Sonesta Boston\, 40\, Edwin H Land Boulevard\, Cambridg
 e\, Massachusetts\, 02142\,
SEQUENCE:0
SUMMARY:As of 2023\, more than 10 bispecific antibodies have been successf
 ully approved by the FDA\, and more than 100 are currently in clinical tr
 ials\, high...
UID:3ed0b39d-60fe-4aa1-aec9-de15e412fd97
END:VEVENT
END:VCALENDAR